Table 1. Hystological and biological profile of the panel of breast cancer cell lines.

Cell line	Hormonalreceptor status	HER2 expression	Disease
BT474	Positive	Positive	Ductal carcinoma
KPL-4	Negative	Positive	Adenocarcinoma
SUM159	Negative	Negative	Mesenchymal
MCF-7	Positive	Negative	Adenocarcinoma
MDA-MB231	Negative	Negative	Adenocarcinoma
MDA-MB468	Negative	Negative	Adenocarcinoma

1. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10:515–27.

2. Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung MC, Bonfiglio T, Hicks DG, Tang P. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer (Auckl). 2010.

3. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One. 2009; 3;4:e6146.